Transmucosal Drug Delivery Market By Delivery Route ( Buccal cavity, Nasal cavity, Vagina ), By Drug Type ( Buccal tablets, Oral sprays, Sublingual films and wafers, Gels ), Industry Trends, Estimation & Forecast, 2017 - 2025

Transmucosal Drug Delivery Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.

Market Overview:

Advancements and continuous research in the delivery systems for drug in humans has paved the way for transmucosal drug delivery market in the recent years. It is a lucrative market with numerous opportunities for the players involved in its value chain. Transmucosal drug delivery is gaining high adoption as compared to the other drug delivery systems, as it allows drugs to avoid the natural defense mechanism of the body. Most of the prescribed drugs when administered via other delivery routes become ineffective due to the body’s defense mechanisms such as harsh gastrointestinal environment and first pass liver metabolism. The transmucosal route mainly includes the buccal, nasal, and vaginal cavities that have a permeable membrane with a rich blood flow. Thus, the administered drugs can easily be directed into the circulatory system and delivered at the target sites. The mucous membranes that are mainly present in the mouth and nose have 4-400 times higher permeability than the epidermal membranes, and thus act as an effective drug delivery system. Moreover, the surging trend of home care and self-administered drugs, mainly in the western countries, are also important determinants fuelling the growth of global transmucosal drug delivery market. In addition, the rising incidences of HIV, stroke, migraine, and osteoporosis among few others is expected to create huge growth opportunities for the market players during the upcoming years. The report provides detailed qualitative and quantitative analysis of the transmucosal drug delivery market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for both the segments namely delivery route and drug type in each of the major regions.

Transmucosal Drug Delivery Market Segmentation

By Delivery route • Buccal cavity • Nasal cavity • Vagina • Others (eye, gastrointestinal tract, oesophagus, rectal drug delivery) By Drug type • Buccal tablets • Oral sprays • Sublingual films and wafers • Gels • Others (medicated confectionery) By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. TRANSMUCOSAL DRUG DELIVERY MARKET OVERVIEW 2.1. TRANSMUCOSAL DRUG DELIVERY MARKET INTRODUCTION 2.2. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Transmucosal Drug Delivery Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Transmucosal Drug Delivery Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Transmucosal Drug Delivery Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRICE TREND, 2017-2025 2.6.1. Global Transmucosal Drug Delivery Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY DRUG TYPE, 2017-2025 3.1. BUCCAL TABLETS 3.2. ORAL SPRAYS 3.3. SUBLINGUAL FILMS AND WAFERS 3.4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE BY DRUG TYPE, 2017-2025 3.4.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Share (%) By Drug type, 2017-2025 3.4.2. Buccal tablets Market Revenue and Growth Rate, 2017-2025 3.4.3. Oral sprays Market Revenue and Growth Rate, 2017-2025 3.4.4. Sublingual films and wafers Market Revenue and Growth Rate, 2017-2025 3.5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION BY DRUG TYPE, 2017-2025 3.5.1. Global Transmucosal Drug Delivery Market Production (Volume) and Share (%) By Drug type, 2017-2025 3.5.2. Buccal tablets Market Production and Growth Rate, 2017-2025 3.5.3. Oral sprays Market Production and Growth Rate, 2017-2025 3.5.4. Sublingual films and wafers Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other drug type segment. CHAPTER 4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY DELIVERY ROUTE, 2017-2025 4.1. BUCCAL CAVITY 4.2. NASAL CAVITY 4.3. VAGINA 4.4. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE BY DELIVERY ROUTE, 2017-2025 4.4.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Share (%) By Delivery route, 2017-2025 4.4.2. Buccal cavity Market Revenue and Growth Rate, 2017-2025 4.4.3. Nasal cavity Market Revenue and Growth Rate, 2017-2025 4.4.4. Vagina Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET CONSUMPTION BY DELIVERY ROUTE, 2017-2025 4.5.1. Global Transmucosal Drug Delivery Market Consumption (Volume) and share (%) By Delivery route, 2017-2025 4.5.2. Buccal cavity Market Consumption and Growth Rate, 2017-2025 4.5.3. Nasal cavity Market Consumption and Growth Rate, 2017-2025 4.5.4. Vagina Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for other delivery route segment. CHAPTER 5. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 31 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Transmucosal Drug Delivery Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Transmucosal Drug Delivery Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Transmucosal Drug Delivery Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL TRANSMUCOSAL DRUG DELIVERY MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL TRANSMUCOSAL DRUG DELIVERY PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Transmucosal Drug Delivery Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL TRANSMUCOSAL DRUG DELIVERY REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Transmucosal Drug Delivery Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. TRANSMUCOSAL DRUG DELIVERY MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Transmucosal Drug Delivery Market Share (%) of Top 3 Manufacturers 8.3.2. Transmucosal Drug Delivery Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL TRANSMUCOSAL DRUG DELIVERY MANUFACTURERS ANALYSIS 9.1. DURECT CORPORATION 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Transmucosal Drug Delivery Product Details 9.1.4. DURECT Corporation Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.2. PANTEC BIOSOLUTIONS AG 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Transmucosal Drug Delivery Product Details 9.2.4. Pantec Biosolutions AG Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.3. ACRUX LIMITED 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Transmucosal Drug Delivery Product Details 9.3.4. Acrux Limited Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.4. MYLAN, INC. 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Transmucosal Drug Delivery Product Details 9.4.4. Mylan, Inc. Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.5. ALZA CORPORATION 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Transmucosal Drug Delivery Product Details 9.5.4. ALZA Corporation Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.6. ANTARES PHARMA, INC. 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Transmucosal Drug Delivery Product Details 9.6.4. Antares Pharma, Inc. Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.7. NOVEN PHARMACEUTICALS, INC. 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Transmucosal Drug Delivery Product Details 9.7.4. Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.8. 3M PHARMACEUTICALS 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Transmucosal Drug Delivery Product Details 9.8.4. 3M Pharmaceuticals Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.9. APRICUS BIOSCIENCES, INC 9.9.1. Business Overview 9.9.2. Company Basic Information 9.9.3. Transmucosal Drug Delivery Product Details 9.9.4. Apricus BioSciences, Inc Transmucosal Drug Delivery Production, Revenue and Gross Margin 9.10. CORIUM INTERNATIONAL, INC 9.10.1. Business Overview 9.10.2. Company Basic Information 9.10.3. Transmucosal Drug Delivery Product Details 9.10.4. Corium International, Inc Transmucosal Drug Delivery Production, Revenue and Gross Margin CHAPTER 10. TRANSMUCOSAL DRUG DELIVERY MARKET VALUE CHAIN ANALYSIS 10.1. TRANSMUCOSAL DRUG DELIVERY INDUSTRIAL CHAIN ANALYSIS 10.2. TRANSMUCOSAL DRUG DELIVERY KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4

• DURECT Corporation
• Pantec Biosolutions AG
• Acrux Limited
• Mylan, Inc.
• ALZA Corporation
• Antares Pharma, Inc.
• Noven Pharmaceuticals, Inc.
• 3M Pharmaceuticals
• Apricus BioSciences, Inc
• Corium International, Inc
• TEVA Pharmaceutical Industries Ltd.
• Generex Biotechnology Corporation
• Aveva Drug Delivery Systems
• MedPharm LTD
• Zosano Pharma
• Nitto Denko Corporation
• Tapemark
• Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
• tesa Labtec GmbH
• Inovio Pharmaceuticals, Inc.
• Nemaura Pharma Ltd

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS